Prospective cohort study shows modified medium-length catheter reduces venous complications in advanced cancer patients, indicating better economic performance.
Background: Deep vein catheterization is common in patients with advanced cancer, but safety and cost comparisons between catheter types are limited. Purpose: To evaluate the safety and economic impact of a modified medium-length catheter versus a standard peripherally inserted central catheter (PICC) line in patients with advanced cancer. Methods: A prospective cohort study was conducted involving 160 patients with advanced cancer receiving palliative care between January 2022 and April 2024. Patients were randomized to a study group (modified medium-length catheter) or control group (PICC line). Venous complications, satisfaction, and costs were compared. Results: The study group had lower rates of venous thrombosis, bleeding, and catheter infection. Patient satisfaction and costs were also significantly better in the study group. Conclusions: The modified medium-length catheter provides better safety, higher satisfaction, and reduced costs, making it a preferred option for patients with advanced cancer.
No takes yet. Share an insight, caveat, or question.
Yu et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: